MedTrace Logo

Epidermal Delivery of Ani-Aging Ingredients

NCT01847066 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2013-05-06

No results posted yet for this study

Summary

To assess the safety and efficacy of an ablative fractional, 2940-nm laser combined with the US Impact and cosmetic -formulations for improving the appearance of wrinkles, acne scars and pigmented skin.

Conditions

  • Wrinkles
  • Acne Scars
  • Pigmentation

Interventions

DEVICE

Erbium 2940 plus cosmetics plus Impact

Laser used in all arms

DEVICE

Erbium 2940 plus cosmetics

laser

Sponsors & Collaborators

  • Alma Lasers Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01847066 on ClinicalTrials.gov